Plunkett Research Online: Zynerba Pharmaceuticals

ZYNERBA PHARMACEUTICALS (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric c.....


ZYNERBA PHARMACEUTICALS

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 484 581-7505
Fax:
Address: 80 West Lancaster Avenue
Devon, PA 19333 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Harmony Biosciences Holdings Inc

Contacts Description

Armando AnidoCEO/Chairman of the Board/Director
James FickenscherCFO/Chief Accounting Officer/Vice President, Divisional
See More
Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric c.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture